Feature | March 27, 2013

Biotronik Iforia is World’s First DF4 ICD/CRT-D Approved for MRI

First implantations of the device taking place worldwide

Biotronik Iforia ICD/CRT-D CE-Approval

March 27, 2013 — Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D series approved for MRI (magnetic resonance imaging). In addition it contains one of the world’s smallest ICDs, the Iforia single chamber ICD.

Aside from featuring ProMRI technology, which allows patients to undergo potentially life-saving MRI scans, Iforia also includes the industry standard DF4 connector system, which is designed to simplify and shorten the implantation procedure. The DF4 connector combines the traditional three connectors into one, allowing for a more convenient implantation procedure without compromising safety.

One of the first implanters, Ching Chi Keong, M.D., of National Heart Centre Singapore, said, “With the Iforia series I can provide my patients with a small and highly reliable ICD and CRT-D series. It includes an impressive range of state-of-the-art innovations including ProMRI and home monitoring. In addition the DF4 technology simplifies the implantation procedure, while the small size of the device makes it more comfortable for the patient and also leads to a better cosmetic result.”

The Iforia series is one of the smallest ICDs and CRT-Ds on the market. In addition the Iforia single chamber ICD has a longevity of more than 11 years and the Iforia CRT-D of more than seven years. This allows for a low replacement rate, benefitting both patients and the healthcare system.

“Safety and reliability are the foundation of all of our new technologies and innovations,” said Christoph Böhmer, president international of Biotronik. “Iforia offers enhanced diagnostic possibilities with the highest reliability and unsurpassed longevity... The new Iforia series combined with ProMRI and Biotronik Home Monitoring offers physicians and patients the best combination of reliability and innovation.”

The European market release of the Iforia series is expected in mid-2013. The first implanters of Biotronik's Iforia ICDs and CRT-Ds are:

  • Prof. Dr. Steffen Behrens, Vivantes Humboldt Hospital Berlin, Germany;
  • Ching Chi Keong, M.D., National Heart Centre Singapore, Singapore;
  • Dr. Thomas Faber, University Heart Centre Freiburg, Germany;
  • Prof. Dr. Stephan B. Felix and Dr. Mathias Busch, University Hospital Greifswald, Germany;
  • Dr. Peter Lercher and Dr. Günther Prenner, LKH-University Clinic Graz, Austria;
  • Abdulmohsen al Musaad, M.D., National Guard Health Affairs Hospital, Riyadh, Saudi Arabia;
  • Dr. Antti Ylitalo and Dr. Tuomas Paana, Satakunta Central Hospital, Pori, Finland.

For more information: www.biotronik.com

Related Content

Niobe remote magnetic navigation system, cardiac abltion, Robert Wood Johnson University Hospital, New Jersey, 500 procedures
News | Robotic Systems| October 25, 2016
Stereotaxis Inc. and Robert Wood Johnson University Hospital (RWJUH) announced that Zyad Younan, M.D., has completed...
UAB, University of Alabama at Birmingham study, stroke prevention, non-valvular atrial fibrillation, NVAF
News | Atrial Fibrillation| October 25, 2016
A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compares different...
iSmartweaR, smart clothing, jIndustrial Technology Research Institute, ITRI, wearable heart monitoring

An example of an iSmartweaR shirt that can monitor patient vital signs without the need for electrode wires.

News | Wearable Sensors| October 24, 2016
October 24, 2016 — Conventional smart clothing uses conductive fibers or rubber as sensing electrodes, and cardiac el
Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
Medtronic, FIRE AND ICE trial, Arctic Front, cryoballoon catheter ablation, radiofrequency RF ablation, study results, Asia Pacific Heart Rhythm Society Scientific Sessions
News | Ablation Systems| October 17, 2016
Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon...
Medtronic, FDA approval, MRI, MR-conditional scanning, cardiac devices
Technology | EP Lab| October 13, 2016
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac...
News | Renal Denervation| October 11, 2016
Awards from the National Institutes of Health’s Common Fund are supporting research on the peripheral nervous system,...
ZipLine Medical, Zip Surgical Skin Closure, cath lab time savings, PACE study
News | EP Lab| October 10, 2016
October 10, 2016 — ZipLine Medical Inc.
St. Jude Medical, Ensite Precision cardiac mapping system, full European market release
News | EP Mapping and Imaging Systems| October 06, 2016
St. Jude Medical Inc. announced a full market release of its EnSite Precision cardiac mapping system and new Sensor...
Overlay Init